$MASS
908 Devices Inc.

2024 Q1 Form 10-K Financial Statement

#000155837024002818 Filed on March 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $9.991M $14.35M $50.23M
YoY Change 5.31% 23.26% 7.21%
Cost Of Revenue $4.988M $7.076M $24.91M
YoY Change -2.25% 23.68% 19.58%
Gross Profit $5.003M $7.275M $25.32M
YoY Change 14.12% 22.85% -2.69%
Gross Profit Margin 50.08% 50.69% 50.41%
Selling, General & Admin $11.90M $11.43M $46.18M
YoY Change -0.85% -1.43% 5.23%
% of Gross Profit 237.88% 157.14% 182.36%
Research & Development $5.790M $5.444M $21.90M
YoY Change 7.26% 16.77% 25.17%
% of Gross Profit 115.73% 74.83% 86.5%
Depreciation & Amortization $1.328M $405.0K $2.384M
YoY Change 109.46% -29.81% 47.71%
% of Gross Profit 26.54% 5.57% 9.41%
Operating Expenses $17.69M $16.99M $68.08M
YoY Change 1.67% 4.48% 10.87%
Operating Profit -$12.69M -$9.713M -$42.76M
YoY Change -2.53% -6.05% 20.85%
Interest Expense $1.729M $2.325M $201.0K
YoY Change 213.79% 18.02% 55.81%
% of Operating Profit
Other Income/Expense, Net $1.701M -$43.00K $6.148M
YoY Change 250.72% -107.86% 237.99%
Pretax Income -$10.99M -$7.431M -$36.61M
YoY Change -12.33% -24.1% 9.08%
Income Tax -$70.00K -$2.000K -$200.0K
% Of Pretax Income
Net Earnings -$10.90M -$7.429M -$36.40M
YoY Change -12.8% -24.12% 8.33%
Net Earnings / Revenue -109.1% -51.77% -72.47%
Basic Earnings Per Share -$0.33 -$1.13
Diluted Earnings Per Share -$0.33 -$0.23 -$1.13
COMMON SHARES
Basic Shares Outstanding 32.91M 32.38M 32.24M
Diluted Shares Outstanding 32.71M 32.24M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $134.2M $145.7M $145.7M
YoY Change -16.76% -22.68% -22.68%
Cash & Equivalents $104.6M $121.0M $121.0M
Short-Term Investments $29.60M $24.64M $24.64M
Other Short-Term Assets $3.831M $4.181M $4.181M
YoY Change -26.16% -10.24% -10.24%
Inventory $16.36M $14.94M $14.94M
Prepaid Expenses
Receivables $7.486M $8.989M $8.989M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $161.9M $173.8M $173.8M
YoY Change -13.87% -19.4% -19.4%
LONG-TERM ASSETS
Property, Plant & Equipment $3.215M $3.342M $9.575M
YoY Change 5.58% 8.4% 36.03%
Goodwill $10.14M $10.37M
YoY Change -0.8% 3.15%
Intangibles $7.468M $7.860M
YoY Change -11.22% -7.4%
Long-Term Investments
YoY Change
Other Assets $1.347M $1.389M $1.389M
YoY Change 11.78% 0.36% 0.36%
Total Long-Term Assets $27.92M $29.19M $29.19M
YoY Change -8.33% 8.27% 8.27%
TOTAL ASSETS
Total Short-Term Assets $161.9M $173.8M $173.8M
Total Long-Term Assets $27.92M $29.19M $29.19M
Total Assets $189.8M $203.0M $203.0M
YoY Change -13.1% -16.33% -16.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.472M $1.191M $1.191M
YoY Change -15.16% -14.75% -88.37%
Accrued Expenses $5.299M $8.713M $10.73M
YoY Change -26.69% -1.51% 630.86%
Deferred Revenue $10.48M $10.63M
YoY Change 31.07% 41.46%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.33M $22.55M $22.55M
YoY Change 3.61% 17.28% 17.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $11.25M $12.50M $12.50M
YoY Change 8900.8% 2152.25% -29.63%
Total Long-Term Liabilities $11.25M $12.50M $12.50M
YoY Change 8900.8% -19.64% -61.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.33M $22.55M $22.55M
Total Long-Term Liabilities $11.25M $12.50M $12.50M
Total Liabilities $32.90M $37.49M $37.49M
YoY Change -12.96% -27.89% -27.89%
SHAREHOLDERS EQUITY
Retained Earnings -$181.5M -$170.6M
YoY Change 23.72% 27.12%
Common Stock $33.00K $33.00K
YoY Change 3.13% 3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $156.9M $165.5M $165.5M
YoY Change
Total Liabilities & Shareholders Equity $189.8M $203.0M $203.0M
YoY Change -13.1% -16.33% -16.33%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$10.90M -$7.429M -$36.40M
YoY Change -12.8% -24.12% 8.33%
Depreciation, Depletion And Amortization $1.328M $405.0K $2.384M
YoY Change 109.46% -29.81% 47.71%
Cash From Operating Activities -$9.357M -$1.930M -$25.06M
YoY Change -12.12% -62.28% 19.73%
INVESTING ACTIVITIES
Capital Expenditures $903.0K $333.0K $2.045M
YoY Change -23.8% -45.59% 0.0%
Acquisitions
YoY Change
Other Investing Activities -$4.877M $4.969M -$24.36M
YoY Change 76.97%
Cash From Investing Activities -$5.780M $4.636M -$26.40M
YoY Change 387.76% -857.52% 67.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.295M 95.00K -15.94M
YoY Change -91.58% -76.89% -1451.57%
NET CHANGE
Cash From Operating Activities -9.357M -1.930M -25.06M
Cash From Investing Activities -5.780M 4.636M -26.40M
Cash From Financing Activities -1.295M 95.00K -15.94M
Net Change In Cash -16.44M 2.801M -67.38M
YoY Change -39.57% -152.68% 89.59%
FREE CASH FLOW
Cash From Operating Activities -$9.357M -$1.930M -$25.06M
Capital Expenditures $903.0K $333.0K $2.045M
Free Cash Flow -$10.26M -$2.263M -$27.10M
YoY Change -13.29% -60.49% 17.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q4 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001555279
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31859847
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32519023
CY2022Q4 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q4 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023 us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
P1Y
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39815
CY2023 dei Entity Registrant Name
EntityRegistrantName
908 DEVICES INC
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4524096
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
645 Summer Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023 dei City Area Code
CityAreaCode
857
CY2023 dei Local Phone Number
LocalPhoneNumber
254-1500
CY2023 dei Trading Symbol
TradingSymbol
MASS
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
165500000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32909929
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers, LLP
CY2023 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121041000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188422000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
24641000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
395000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8989000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10033000
CY2023Q4 us-gaap Inventory Net
InventoryNet
14938000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12513000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4181000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4658000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
173790000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
215626000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6233000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3956000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3342000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3083000
CY2023Q4 us-gaap Goodwill
Goodwill
10367000
CY2022Q4 us-gaap Goodwill
Goodwill
10050000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7860000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8488000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1389000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1384000
CY2023Q4 us-gaap Assets
Assets
202981000
CY2022Q4 us-gaap Assets
Assets
242587000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1191000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1397000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8713000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8847000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10629000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7514000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2016000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1468000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22549000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19226000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15000000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3929000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3040000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8571000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11496000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2441000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2671000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
555000
CY2023Q4 us-gaap Liabilities
Liabilities
37490000
CY2022Q4 us-gaap Liabilities
Liabilities
51988000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32519023
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31859847
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
334692000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
323969000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1365000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
798000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170599000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134200000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
165491000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
190599000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
202981000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242587000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50229000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46852000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
24907000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
20829000
CY2023 us-gaap Gross Profit
GrossProfit
25322000
CY2022 us-gaap Gross Profit
GrossProfit
26023000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21904000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17526000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46176000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43879000
CY2023 us-gaap Operating Expenses
OperatingExpenses
68080000
CY2022 us-gaap Operating Expenses
OperatingExpenses
61405000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-42758000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-35382000
CY2023 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
6480000
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2031000
CY2023 us-gaap Interest Expense
InterestExpense
201000
CY2022 us-gaap Interest Expense
InterestExpense
129000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6148000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1819000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36610000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33563000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36399000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-33563000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32239394
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32239394
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31492531
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31492531
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36399000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-33563000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
554000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
798000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
13000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
567000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
798000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35832000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32765000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
214604000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1022000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7207000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
531000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
798000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-33563000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
190599000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
432000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9787000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
505000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
554000
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
13000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36399000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
165491000
CY2023 us-gaap Profit Loss
ProfitLoss
-36399000
CY2022 us-gaap Profit Loss
ProfitLoss
-33563000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2384000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1614000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
9787000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
7207000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-192000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-47000
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
663000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
376000
CY2023 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
301000
CY2023 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
386000
CY2023 mass Fair Value Adjustment Of Contingent Consideration
FairValueAdjustmentOfContingentConsideration
-107000
CY2022 mass Fair Value Adjustment Of Contingent Consideration
FairValueAdjustmentOfContingentConsideration
-161000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-305000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-129000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-680000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5930000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3902000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5475000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
513000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-844000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
135000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
93000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2033000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
452000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
179000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1892000
CY2023 mass Increase Decrease In Right Of Use Operating Assets
IncreaseDecreaseInRightOfUseOperatingAssets
-1668000
CY2022 mass Increase Decrease In Right Of Use Operating Assets
IncreaseDecreaseInRightOfUseOperatingAssets
-1226000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1583000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1344000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-75000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25059000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20930000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2045000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2045000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
48874000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24519000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13762000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26400000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15807000
CY2023 mass Payments For Withholding Taxes On Vested Awards
PaymentsForWithholdingTaxesOnVestedAwards
776000
CY2022 mass Payments For Withholding Taxes On Vested Awards
PaymentsForWithholdingTaxesOnVestedAwards
262000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
936000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1553000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
112000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
60000000
CY2023 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000
CY2022 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
60000000
CY2023 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1095000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15935000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1179000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-67381000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35540000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188593000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224133000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121212000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188593000
CY2023 mass Property And Equipment Included In Account Payable
PropertyAndEquipmentIncludedInAccountPayable
23000
CY2022 mass Property And Equipment Included In Account Payable
PropertyAndEquipmentIncludedInAccountPayable
219000
CY2023 mass Transfers Of Inventory To Property And Equipment
TransfersOfInventoryToPropertyAndEquipment
1047000
CY2022 mass Transfers Of Inventory To Property And Equipment
TransfersOfInventoryToPropertyAndEquipment
887000
CY2023 mass Transfers Of Property And Equipment To Inventory
TransfersOfPropertyAndEquipmentToInventory
214000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121041000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188422000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
60000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
171000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
111000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121212000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188593000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
135000
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2012-02-10
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36400000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-33600000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170600000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, revenue recognition and accounts receivable, the valuation of inventory, fair value of assets acquired and liabilities assumed in acquisitions and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Due to the rising inflation and higher interest rates, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require further updates to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these consolidated financial statements. These estimates may change, as new events occur and additional information is obtained. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Risk of Concentrations of Credit, Significant Customers and Significant Suppliers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The Company’s cash and cash equivalents and restricted cash are maintained in bank deposit accounts and money market funds that regularly exceed federally insured limits. The Company is exposed to credit risk on its cash, cash equivalents and restricted cash in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s marketable securities are invested in U.S. treasury securities and as a result, the Company believes represent minimal credit risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Significant customers are those that accounted for 10% or more of the Company’s total revenue or accounts receivable. One customer represented 21% of total revenue for the year ended December 31, 2023. One customer </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">represented 28% of total revenue for the year ended December 31, 2022. As of December 31, 2023, one customer accounted for 19% of gross accounts receivable. As of December 31, 2022, two customers accounted for 20% and 12%, respectively, of gross accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain of the components included in the Company’s products are obtained from a sole source, a single source or a limited group of suppliers. Although the Company seeks to reduce dependence on those limited sources of suppliers and manufacturers, the partial or complete loss of certain of these sources, or the requirement to establish a new supplier for the components, could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.</p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1750000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
386000
CY2023 mass Allowance For Doubtful Accounts Receivable Net Recoveries Deductions
AllowanceForDoubtfulAccountsReceivableNetRecoveriesDeductions
-16000
CY2022 mass Allowance For Doubtful Accounts Receivable Net Recoveries Deductions
AllowanceForDoubtfulAccountsReceivableNetRecoveriesDeductions
-1725000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
395000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000
CY2023 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50229000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46852000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50229000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46852000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1800000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1800000
CY2023Q4 mass Accumulated Accretion And Relative Contingent Consideration
AccumulatedAccretionAndRelativeContingentConsideration
0
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1798000
CY2023 mass Accretion In Fair Value Of Contingent Consideration Earnout
AccretionInFairValueOfContingentConsiderationEarnout
356000
CY2023 mass Deduction In Fair Value Of Contingent Consideration Earnout
DeductionInFairValueOfContingentConsiderationEarnout
249000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1405000
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
500000
CY2023Q2 mass Business Combination Contingent Consideration Pension Liability Released
BusinessCombinationContingentConsiderationPensionLiabilityReleased
900000
CY2022 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
0
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
877000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
343000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11294000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8343000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1717000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2722000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1927000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1448000
CY2023Q4 us-gaap Inventory Net
InventoryNet
14938000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12513000
CY2023 mass Inventory Non Cash Transfers To Property Plant And Equipment
InventoryNonCashTransfersToPropertyPlantAndEquipment
1000000.0
CY2022 mass Inventory Non Cash Transfers To Property Plant And Equipment
InventoryNonCashTransfersToPropertyPlantAndEquipment
900000
CY2023Q4 us-gaap Goodwill
Goodwill
10400000
CY2022Q4 us-gaap Goodwill
Goodwill
10050000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
317000
CY2023Q4 us-gaap Goodwill
Goodwill
10367000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8424000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1220000
CY2023 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
656000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7860000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8424000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
343000
CY2022 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
407000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8488000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
860000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
841000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
775000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
765000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
765000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
3854000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7860000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9289000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7800000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5947000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4717000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3342000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3083000
CY2023 us-gaap Depreciation
Depreciation
1500000
CY2022 us-gaap Depreciation
Depreciation
1300000
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.070
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5994000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4909000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
942000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1119000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
560000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
677000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
500000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1243000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
717000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
899000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8713000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8847000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1119000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1593000
CY2023 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1273000
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1396000
CY2023 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1450000
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1870000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
942000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1119000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15000000
CY2020Q4 mass Total Shares Authorized
TotalSharesAuthorized
105000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10311000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14917000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
14855000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12768000
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3400000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9787000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7207000
CY2023 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
2176000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
2337000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
70000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
43000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
133000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
9000
CY2023 us-gaap Lease Cost
LeaseCost
2379000
CY2022 us-gaap Lease Cost
LeaseCost
2389000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
2118000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3017000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y11M15D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.084
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2432000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2002000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
581000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
595000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
509000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
838000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6957000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1012000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5945000
CY2023Q4 mass Number Of Parties With Royalty Arrangements
NumberOfPartiesWithRoyaltyArrangements
2
CY2023Q4 mass Royalty Liabilities Future Minimum Royalty Payments Annual
RoyaltyLiabilitiesFutureMinimumRoyaltyPaymentsAnnual
100000
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
CY2023Q4 mass Accumulated Accretion And Relative Contingent Consideration
AccumulatedAccretionAndRelativeContingentConsideration
0
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4414595
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3623597
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.032
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.047
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.050
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.051
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.031
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.017
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.255
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.325
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.006
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27221000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23210000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
10557000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
8722000
CY2023Q4 mass Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
1362000
CY2022Q4 mass Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
1139000
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2527000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3268000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
5421000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
4314000
CY2023Q4 mass Deferred Tax Assets Research And Development Capitalized
DeferredTaxAssetsResearchAndDevelopmentCapitalized
7172000
CY2022Q4 mass Deferred Tax Assets Research And Development Capitalized
DeferredTaxAssetsResearchAndDevelopmentCapitalized
3857000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
54260000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44510000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1394000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1000000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2482000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2671000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3876000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3671000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52825000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43510000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2441000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2671000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43510000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32631000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9315000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10879000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52825000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43510000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
9575000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
7915000
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
238

Files In Submission

Name View Source Status
0001558370-24-002818-index-headers.html Edgar Link pending
0001558370-24-002818-index.html Edgar Link pending
0001558370-24-002818.txt Edgar Link pending
0001558370-24-002818-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mass-20231231.xsd Edgar Link pending
mass-20231231x10k.htm Edgar Link pending
mass-20231231x10k001.jpg Edgar Link pending
mass-20231231x10k002.jpg Edgar Link pending
mass-20231231x10k003.jpg Edgar Link pending
mass-20231231x10k004.jpg Edgar Link pending
mass-20231231x10k005.jpg Edgar Link pending
mass-20231231x10k006.jpg Edgar Link pending
mass-20231231x10k007.jpg Edgar Link pending
mass-20231231xex10d18.htm Edgar Link pending
mass-20231231xex10d4.htm Edgar Link pending
mass-20231231xex21d1.htm Edgar Link pending
mass-20231231xex23d1.htm Edgar Link pending
mass-20231231xex31d1.htm Edgar Link pending
mass-20231231xex31d2.htm Edgar Link pending
mass-20231231xex32d1.htm Edgar Link pending
mass-20231231xex32d2.htm Edgar Link pending
mass-20231231xex97.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mass-20231231_cal.xml Edgar Link unprocessable
mass-20231231_def.xml Edgar Link unprocessable
mass-20231231_lab.xml Edgar Link unprocessable
mass-20231231_pre.xml Edgar Link unprocessable
mass-20231231x10k_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending